InvestorsHub Logo
Followers 8
Posts 596
Boards Moderated 0
Alias Born 01/30/2017

Re: None

Wednesday, 11/22/2017 8:21:57 AM

Wednesday, November 22, 2017 8:21:57 AM

Post# of 74456

The Company will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.